WIFI, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer

Journal of Pathology

Volumn 201, Issue 2, 2003, Pages 204-212

  Wissman, Cristoph ^a   Wild, Peter Johannes ^b   Kaiser, Simone ^a   Roepcke, Stefan ^a   Stoehr, Robert ^b   Woenckhaus, Matthias ^b   Kristiansen, Glen ^c   Hsieh, Jen Chih ^d   Hofstaedter, Ferdinand ^b   Hartmann, Arndt ^b,e   Knuechel, Ruth ^b   Rosenthal, André ^a   Pilarsky, Christian ^a,f  

^a MetaGen Pharmaceuticals GmbH   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Bladder; Breast; Cancer; Immunohistochemistry; Lung; Prostate; WIF1

Indexed keywords

HERMES ANTIGEN; MEMBRANE RECEPTOR; ONCOPROTEIN; POLYCLONAL ANTIBODY; RNA; WNT PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER; WIF 1 PROTEIN, MOUSE; WIF-1 PROTEIN, MOUSE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER TUMOR; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; BREAST TUMOR; CHEMISTRY; DNA MICROARRAY; GENETICS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; NEOPLASM; NONPARAMETRIC TEST; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE;

AGED; BLOTTING, NORTHERN; BREAST NEOPLASMS; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0141995804     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1449     Document Type: Article

References (37)

1. Welsh JB, Sapinoso LM, Su AI, et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61: 5974-5978.
2. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.
3. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001; 98: 13784-13789.
4. Thykjaer T, Workman C, Kruhoffer M, et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 2001; 61: 2492-2499.
5. Schmitt AO, Specht T, Beckmann G, et al. Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res 1999; 27: 4251-4260.
6. Morin PJ, Sparks AB, Korinek V, et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-1790.
7. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130-1134.
8. Bienz MClevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320.
9. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851.
10. Arias AM, Brown AM, Brennan K. Wnt signalling: pathway or network? Curr Opin Genet Dev 1999; 9: 447-454.
11. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31: 99-109.
12. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 15-21.
13. Shimizu H, Julius MA, Giarre M, et al. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 1997; 8: 1349-1358.
14. Bui TD, Rankin J, Smith K, et al. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene 1997; 14: 1249-1253.
15. Vider BZ, Zimber A, Chastre E, et al. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996; 12: 153-158.
16. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1: 279-288.
17. Rattner A, Hsieh JC, Smallwood PM, et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A 1997; 94: 2859-2863.
18. Melkonyan HS, Chang WC, Shapiro JP, et al. SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A 1997; 94: 13636-13641.
19. Zhou Z, Wang J, Han X, et al. Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer 1998; 78: 95-99.
20. Ugolini F, Adelaide J, Charafe-Jauffret E, et al. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 1999; 18: 1903-1910.
21. Ugolini F, Charafe-Jauffret E, Bardou VJ, et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001; 20: 5810-5817.
22. Wong SC, Lo SF, Lee KC, et al. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 2002; 196: 145-153.
23. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature Genet 2002; 31: 141-149.
24. Hsieh JC, Kodjabachian L, Rebbert ML, et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999; 398: 431-436.
25. Kristiansen G, Pilarsky C, Wissmann C, et al. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 2003; 54: 34-43.
26. Luo L, Salunga RC, Guo H, et al. Gene expression profiles of laser-captured adjacent neuronal subtypes. Nature Med 1999; 5: 117-122.
27. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RTPCR after laser-assisted cell picking. Nature Med 1998; 4: 1329-1333.
28. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000; 287: 1606-1609.
29. Sagara N, Toda G, Hirai M, et al. Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7. Biochem Biophys Res Commun 1998; 252: 117-122.
30. Bui TD, O'Brien T, Crew J, et al. High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer. Br J Cancer 1998; 77: 319-324.
31. Stoehr R, Krieg RC, Knuechel R, et al. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Int J Oncol 2002; 20: 905-911.
32. Abu-Jawdeh G, Comella N, Tomita Y, et al. Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab Invest 1999; 79: 439-447.
33. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826.
34. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
35. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001; 98: 13790-13795.
36. Sozzi G. Molecular biology of lung cancer. Eur J Cancer 2001; 37(Suppl 7): S63-S73.
37. Greene FL, Balch CM, Fleming ID, et al. AJCC Cancer Staging Handbook; TNM Classification of Malignant Tumours. Springer: Heidelberg, 2002.